应用于构建优势杂环骨架的交叉脱氢偶联反应

doi:10.6023/cjoc201703033

有机化学 ›› 2017, Vol. 37 ›› Issue (11): 2850-2858.DOI: 10.6023/cjoc201703033 上一篇下一篇

综述与进展

应用于构建优势杂环骨架的交叉脱氢偶联反应

胡玮, 龙亚秋

中国科学院上海药物研究所受体结构和功能重点实验室上海 201203

收稿日期:2017-03-20 修回日期:2017-06-14 发布日期:2017-07-07
通讯作者: 龙亚秋 E-mail:yqlong@simm.ac.cn
基金资助:
国家自然科学基金（Nos.81325020，81761128022）资助项目.

Cross-Dehydrogenative Coupling Reactions Applied in the Construction of Privileged Heterocycles

Hu Wei, Long Yaqiu

CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203

Received:2017-03-20 Revised:2017-06-14 Published:2017-07-07
Contact: 10.6023/cjoc201703033 E-mail:yqlong@simm.ac.cn
Supported by:
Project supported by the National Natural Science Foundation of China (Nos. 81325020, 81761128022).

文章分享

摘要/Abstract

交叉脱氢偶联反应（CDC）是一类不需要预先官能团化、两分子C-H键直接偶联的反应，它具有合成简便、原子经济性高和绿色环保等优点.杂环结构存在于多种药物分子及天然产物中，是承载多种药理活性的药物亚结构，因此被称为类药性优势骨架.采用CDC的策略合成类药性优势骨架具有多种优势，基于优势骨架的类药性化合物库也是发现先导化合物的一种有效途径.按照合成的杂环结构进行分类，对吲哚、吡咯、吡唑、呋喃、喹唑啉等杂环的CDC合成方法进行介绍，综述了近年来CDC反应在类药性优势骨架合成中的应用和特点.

关键词: 交叉脱氢偶联, C-H官能团化, 类药性优势骨架

The reactions in which a new C-C bond is formed via a direct coupling of two C-H bonds are termed as cross dehydrogenative coupling (CDC). The coupling reactions would not need the pre-activation of the inert C-H bonds by any func-tional groups, featured with straightforwardness, atom-and step-economy and environmently benigness. Heterocycles are widely found in bioactive natural products and pharmaceuticals, designated as drug-like privileged scaffolds since they endowed diverse pharmacological effects. Preparation of these privileged structures by means of CDC confers distinctive advantages and enhances the discovery of lead compounds in medicinal chemistry. The application of CDC reactions in the synthesis of the heterocycles of pharmaceutical interest in recent years is summarized, focused on the construction of privileged scaffolds, such as indole, pyrrole, quinazoline, quinoxaline and the middle size and poly ring systems.

Key words: cross-dehydrogenative coupling, C-H functionalization, drug-like privileged scaffold

引用此文

胡玮, 龙亚秋. 应用于构建优势杂环骨架的交叉脱氢偶联反应[J]. 有机化学, 2017, 37(11): 2850-2858.

Hu Wei, Long Yaqiu. Cross-Dehydrogenative Coupling Reactions Applied in the Construction of Privileged Heterocycles[J]. Chin. J. Org. Chem., 2017, 37(11): 2850-2858.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] (a) Wang, M.; Wang, Z.; Shang, M.; Dai, H. Chin. J. Org. Chem. 2015, 35, 570(in Chinese). (王明明, 王子潇, 商明, 戴辉雄, 有机化学, 2015, 35, 570.)
(b) Lu, B.; Li, X.; Lin, Y. Chin. J. Org. Chem. 2015, 35, 2275(in Chinese). (卢贝丽, 李现艳, 林咏梅, 有机化学, 2015, 35, 2275.)
(c) Ding, Z.; Tan, Q.; Liu, B.; Zhang, K.; Xu, B. Acta Chim. Sinica 2015, 73, 1302(in Chinese). (丁正伟, 谭启涛, 刘秉新, 张可, 许斌, 化学学报, 2015, 73, 1302.)
(d) Yu, J.-Q.; Ding, K.-L. Acta Chim. Sinica 2015, 73, 1223(in Chinese). (余金权, 丁奎岭, 化学学报, 2015, 73, 1223.)
[2] (a) Girard, S. A.; Knauber, T.; Li, C.-J. Angew. Chem., Int. Ed. 2014, 53, 74.
(b) Li, G.; Nakamura, H. Angew. Chem., Int. Ed. 2016, 55, 6758.
[3] (a) Li, Z.; Li, C.-J. J. Am. Chem. Soc. 2005, 127, 6968.
(b) Li, Z.; Li, C.-J. J. Am. Chem. Soc. 2006, 128, 56.
(c) Zhang, Y.; Li, C.-J. J. Am. Chem. Soc 2006, 128, 4242.
[4] (a) Zhang, C.; Jiao, N. Angew. Chem., Int. Ed. 2010, 49, 6174.
(b) Han, W.; Mayer, P.; Ofial, A. R. Angew. Chem., Int. Ed. 2011, 50, 2178.
(c) Antonchick, A. P.; Burgmann, L. Angew. Chem., Int. Ed. 2013, 52, 3267.
(d) Meng, Z.; Sun, S.; Yuan, H.; Lou, H.; Liu, L. Angew. Chem., Int. Ed. 2014, 53, 543.
(e) Zhou, L.; Xu, B.; Zhang, J. Angew. Chem., Int. Ed. 2015, 54, 9092.
[5] Gensch, T.; Klauck, F. J. R.; Glorius, F. Angew. Chem., Int. Ed. 2016, 55, 11287.
[6] Lin, J.-P.; Zhang, F.-H.; Long, Y.-Q. Org. Lett. 2014, 16, 2822.
[7] Hu, W.; Lin, J.-P.; Song, L.-R.; Long, Y.-Q. Org. Lett. 2015, 17, 1268.
[8] Zhao, M.; Wang, F.; Li, X. Org. Lett. 2012, 14, 1412.
[9] Vanjari, R.; Guntreddi, T.; Kumar, S.; Singh, K. N. Chem. Commun. 2015, 51, 366.
[10] (a) Wang, L.; Woods, K. W.; Li, Q.; Barr, K. J.; McCroskey, R. W.; Hannick, S. M.; Gherke, L.; Credo, R. B.; Hui, Y.-H.; Marsh, K.; Warner, R.; Lee, J. Y.; Zielinski-Mozng, N.; Frost, D.; Rosenberg, S. H.; Sham, H. L. J. Med. Chem. 2002, 45, 1697.
(b) Zeng, L.-F.; Wang, Y.; Kazemi, R.; Xu, S.; Xu, Z.-L.; Sanchez, T. W.; Yang, L.-M.; Debnath, B.; Odde, S.; Xie, H.; Zheng, Y.-T.; Ding, J.; Neamati, N.; Long, Y.-Q. J. Med. Chem 2012, 55, 9492.
(c) Lam, T.; Hilgers, M. T.; Cunningham, M. L.; Kwan, B. P.; Nelson, K. J.; Brown-Driver, V.; Ong, V.; Trzoss, M.; Hough, G.; Shaw, K. J.; Finn, J. J. Med. Chem. 2014, 57, 651.
[11] Li, C.-J. Acc. Chem. Res. 2009, 42, 335.
[12] Xue, D.; Long, Y.-Q. J. Org. Chem. 2014, 79, 4727.
[13] Zhu, C.; Yang, B.; Qiu, Y.; Backvall, J. E. Angew. Chem., Int. Ed. 2016, 55, 14405.
[14] (a) Cheng, Y.; Shen, J.; Peng, R.-Z.; Wang, G.-F.; Zuo, J.-P.; Long, Y.-Q. Bioorg. Med. Chem. Lett. 2016, 26, 2900.
(b) Zhi, Y.; Gao, L.-X.; Jin, Y.; Tang, C.-L.; Li, J.-Y.; Li, J.; Long, Y.-Q. Bioorg. Med. Chem. 2014, 22, 3670.
[15] (a) Shi, Z.; Glorius, F. Angew. Chem., Int. Ed. 2012, 51, 9220.
(b) Li, J.; Li, C.; Yang, S.; An, Y.; Wu, W.; Jiang, H. J. Org. Chem. 2016, 81, 7771.
(c) Gao, S.; Wu, Z.; Fang, X.; Lin, A.; Yao, H. Org. Lett. 2016, 18, 3906.
(d) Chen, J.; Wu, J. Angew. Chem., Int. Ed. 2017, 56, 3951.
(e) Li, J.; Li, C.; Yang, S.; An, Y.; Wu, W.; Jiang, H. J. Org. Chem. 2016, 81, 2875.
[16] Würtz, S.; Rakshit, S.; Neumann, J. J.; Dröge, T.; Glorius, F. Angew. Chem., Int. Ed. 2008, 120, 7340.
[17] Shi, Z.; Zhang, C.; Li, S.; Pan, D.; Ding, S.; Cui, Y.; Jiao, N. Angew. Chem., Int. Ed. 2009, 48, 4572.
[18] Yu, W.; Du, Y.; Zhao, K. Org. Lett. 2009, 11, 2417.
[19] Guan, Z.-H.; Yan, Z.-Y.; Ren, Z.-H.; Liu, X.-Y.; Liang, Y.-M. Chem. Commun. 2010, 46, 2823.
[20] Zoller, J.; Fabry, D. C.; Ronge, M. A.; Rueping, M. Angew. Chem., Int. Ed. 2014, 53, 13264.
[21] Wei, Y.; Deb, I.; Yoshikai, N. J. Am. Chem. Soc. 2012, 134, 9098.
[22] Jiang, L.; Jin, W.; Hu, W. ACS Catal. 2016, 6, 6146.
[23] Tanitame, A.; Oyamada, Y.; Ofuji, K.; Fujimoto, M.; Iwai, N.; Hiyama, Y.; Suzuki, K.; Ito, H.; Terauchi, H.; Kawasaki, M.; Nagai, K.; Wachi, M.; Yamagishi, J.-I. J. Med. Chem. 2004, 47, 3693.
[24] Wu, C.-H.; Hung, M.-S.; Song, J.-S.; Yeh, T.-K.; Chou, M.-C.; Chu, C.-M.; Jan, J.-J.; Hsieh, M.-T.; Tseng, S.-L.; Chang, C.-P.; Hsieh, W.-P.; Lin, Y.; Yeh, Y.-N.; Chung, W.-L.; Kuo, C.-W.; Lin, C.-Y.; Shy, H.-S.; Chao, Y.-S.; Shia, K.-S. J. Med. Chem. 2009, 52, 4496.
[25] Fustero, S.; Sánchez-Roselló, M.; Barrio, P.; Simón-Fuentes, A. Chem. Rev. 2011, 111, 6984.
[26] Neumann, J. J.; Suri, M.; Glorius, F. Angew. Chem., Int. Ed. 2010, 49, 7790.
[27] (a) Zhang, G.; Zhao, Y.; Ge, H. Angew. Chem., Int. Ed. 2013, 52, 2559.
(b) Wu, X.; Wang, M.; Zhang, G.; Zhao, Y.; Wang, J.; Ge, H. Chem. Sci. 2015, 6, 5882.
[28] Murarka, S.; Studer, A. Org. Lett. 2011, 13, 2746.
[29] Ye, J. T.; Ma, S. M. Acc. Chem. Res. 2014, 47, 989.
[30] Xiao, T.; Li, L.; Lin, G.; Mao, Z.-W.; Zhou, L. Org. Lett. 2014, 16, 4232.
[31] Zhang, Z.; Dai, Z.; Ma, X.; Liu, Y.; Ma, X.; Li, W.; Ma, C. Org. Chem. Front. 2016, 3, 799.
[32] Ackermann, L.; Pospech, J. Org. Lett. 2011, 13, 4153.
[33] Zhang, Z.; Xie, C.; Tan, X.; Song, G.; Wen, L.; Gao, H.; Ma, C. Org. Chem. Front. 2015, 2, 942.
[34] Sun, M.; Zhang, T.; Bao, W. J. Org. Chem. 2013, 78, 8155.
[35] (a) Dhiman, S.; Mishra, U. K.; Ramasastry, S. S. V. Angew. Chem., Int. Ed. 2016, 55, 7737.
(b) Garkhedkar, A. M.; Senadi, G. C.; Wang, J. J. Org. Lett. 2017, 19, 488.
(c) Cheng, J.; Li, W. P.; Duan, Y. Q.; Cheng, Y. X.; Yu, S. Y.; Zhu, C. J. Org. Lett. 2017, 19, 214.
[36] Gaster, E.; Vainer, Y.; Regev, A.; Narute, S.; Sudheendran, K.; Werbeloff, A.; Shalit, H.; Pappo, D. Angew. Chem., Int. Ed. 2015, 54, 4198.

应用于构建优势杂环骨架的交叉脱氢偶联反应

Cross-Dehydrogenative Coupling Reactions Applied in the Construction of Privileged Heterocycles

PDF

可视化

被引次数

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 13

编辑推荐

相关统计

本文评价

[1]	王馨瑶, 张晴晴, 刘书扬, 李敏, 李海芳, 段春迎, 金云鹤. 可见光诱导无金属条件下交叉脱氢偶联反应合成醌类苄基化衍生物[J]. 有机化学, 2022, 42(5): 1443-1452.
[2]	徐东平, 黄飞, 汤琳, 张新明, 张武. 可见光诱导杂芳烃与脂肪醇的羟烷基化反应[J]. 有机化学, 2022, 42(5): 1493-1500.
[3]	田婉群, 李梦媛, 杨霜, 章浩, 刘海洋, 肖新颜. 铜咔咯催化烯丙基sp³-C—H键与羧酸的酯化反应[J]. 有机化学, 2021, 41(7): 2875-2884.
[4]	王浩, 应娉, 俞静波, 苏为科. 交叉脱氢偶联反应构建碳-碳键的可替代策略[J]. 有机化学, 2021, 41(5): 1897-1924.
[5]	陈缘, 夏立静, 常怡婷, 马武珍, 王彬. N-烷基胺类作为多功能砌块在氧化偶联反应中的应用[J]. 有机化学, 2021, 41(5): 1851-1877.
[6]	庄伟辉, 张晓凤, 黄秋锋. 氧气为唯一氧化剂的交叉脱氢偶联反应研究进展[J]. 有机化学, 2021, 41(2): 529-542.
[7]	孔瑶蕾, 徐雯秀, 叶飞霞, 翁建全. 可见光诱导的无过渡金属催化交叉脱氢偶联反应研究进展[J]. 有机化学, 2019, 39(11): 3065-3083.
[8]	金城安, 徐庆, 冯高峰, 金阳, 张连阳. 咪唑并[1,2-a]吡啶C-3位C—H官能团化研究进展[J]. 有机化学, 2018, 38(4): 775-790.
[9]	杨丽烽, 惠人杰, 单恒悦, 巩凯. 碘催化的咪唑类化合物N-H键的官能化[J]. 有机化学, 2017, 37(12): 3242-3247.
[10]	刘薇, 郑昕宇, 曾建国, 程辟. 可见光促进的叔胺C-H官能团化反应[J]. 有机化学, 2017, 37(1): 1-19.
[11]	王明明, 王子潇, 商明, 戴辉雄. 过渡金属催化的C—H炔基化反应[J]. 有机化学, 2015, 35(3): 570-577.
[12]	张艳, 冯柏年. 过渡金属催化的不对称交叉脱氢偶联反应研究进展[J]. 有机化学, 2014, 34(12): 2406-2411.
[13]	张艳, 朱成建. Bu₄NAuCl₄催化的H₂O₂氧化的sp³-C—H键与sp³-C—H键的交叉偶联反应[J]. 有机化学, 2012, 32(11): 2090-2094.